Literature DB >> 32184923

Extramedullary multiple myeloma with central nervous system and multiorgan involvement: Case report and literature review.

Weiyong Lee1,2, Robert Chun Chen2,3, Saravana Kumar Swaminathan4,3, Chi Long Ho1,3,5.   

Abstract

Multiple myeloma is a hematologic malignancy due to monoclonal plasma cell proliferation. It is usually confined to the bone marrow, although extramedullary involvement is known to occur in almost any organ system; myelomatous spread to the central nervous system is a rare manifestation of myeloma. Extramedullary disease is thought to be related to hematogenous spread when myeloma cells show decreased cell surface receptor expression, allowing cells to escape from the bone marrow. Disease outside of the bone marrow generally indicates a poor prognosis; central nervous system involvement is associated with a median prognosis of less than 6 months, thereby requiring more aggressive treatment paradigms. We herein describe an unusual case of a patient with extramedullary multiple myeloma with central nervous system and multiorgan involvement. Despite an aggressive treatment strategy, the patient died a few months later after the initial diagnosis. The etiology, diagnostic criteria, clinical presentation, radiological features and differential diagnosis of this patient with extramedullary multiple myeloma are discussed here. The current treatment strategies are also briefly discussed. Copyright Journal of Radiology Case Reports.

Entities:  

Keywords:  Central nervous system multiple myeloma; extramedullary multiple myeloma; extraosseous multiple myeloma; multiple myeloma; pachymeningeal disease

Mesh:

Year:  2019        PMID: 32184923      PMCID: PMC7060015          DOI: 10.3941/jrcr.v13i12.3784

Source DB:  PubMed          Journal:  J Radiol Case Rep        ISSN: 1943-0922


  18 in total

Review 1.  Imaging manifestations of neurosarcoidosis.

Authors:  J Keith Smith; Maria Gisele Matheus; Mauricio Castillo
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

Review 2.  Updated Diagnostic Criteria and Staging System for Multiple Myeloma.

Authors:  S Vincent Rajkumar
Journal:  Am Soc Clin Oncol Educ Book       Date:  2016

Review 3.  Soft-tissue plasmacytomas in multiple myeloma: incidence, mechanisms of extramedullary spread, and treatment approach.

Authors:  Joan Bladé; Carlos Fernández de Larrea; Laura Rosiñol; María Teresa Cibeira; Raquel Jiménez; Ray Powles
Journal:  J Clin Oncol       Date:  2011-09-06       Impact factor: 44.544

Review 4.  Extramedullary disease in plasma cell myeloma: the iceberg phenomenon.

Authors:  B Wirk; J R Wingard; J S Moreb
Journal:  Bone Marrow Transplant       Date:  2012-03-12       Impact factor: 5.483

Review 5.  Primary dural lymphomas: a review.

Authors:  Fabio M Iwamoto; Lauren E Abrey
Journal:  Neurosurg Focus       Date:  2006-11-15       Impact factor: 4.047

6.  Current concepts in the evaluation of multiple myeloma with MR imaging and FDG PET/CT.

Authors:  Christopher J Hanrahan; Carl R Christensen; Julia R Crim
Journal:  Radiographics       Date:  2010-01       Impact factor: 5.333

7.  Central nervous system involvement by multiple myeloma: A multi-institutional retrospective study of 172 patients in daily clinical practice.

Authors:  Artur Jurczyszyn; Norbert Grzasko; Alessandro Gozzetti; Jacek Czepiel; Alfonso Cerase; Vania Hungria; Edvan Crusoe; Ana Luiza Miranda Silva Dias; Ravi Vij; Mark A Fiala; Jo Caers; Leo Rasche; Ajay K Nooka; Sagar Lonial; David H Vesole; Sandhya Philip; Shane Gangatharan; Agnieszka Druzd-Sitek; Jan Walewski; Alessandro Corso; Federica Cocito; Marie-Christine M Vekemans; Erden Atilla; Meral Beksac; Xavier Leleu; Julio Davila; Ashraf Badros; Ekta Aneja; Niels Abildgaard; Efstathios Kastritis; Dorotea Fantl; Natalia Schutz; Tomas Pika; Aleksandra Butrym; Magdalena Olszewska-Szopa; Lidia Usnarska-Zubkiewicz; Saad Z Usmani; Hareth Nahi; Chor S Chim; Chaim Shustik; Krzysztof Madry; Suzanne Lentzsch; Alina Swiderska; Grzegorz Helbig; Renata Guzicka-Kazimierczak; Nikoletta Lendvai; Anders Waage; Kristian T Andersen; Hirokazu Murakami; Sonja Zweegman; Jorge J Castillo
Journal:  Am J Hematol       Date:  2016-04-24       Impact factor: 10.047

8.  Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients.

Authors:  M Varettoni; A Corso; G Pica; S Mangiacavalli; C Pascutto; M Lazzarino
Journal:  Ann Oncol       Date:  2009-07-24       Impact factor: 32.976

Review 9.  How I treat extramedullary myeloma.

Authors:  Cyrille Touzeau; Philippe Moreau
Journal:  Blood       Date:  2015-12-17       Impact factor: 22.113

10.  Intracranial dural metastases.

Authors:  Lakshmi Nayak; Lauren E Abrey; Fabio M Iwamoto
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

View more
  2 in total

1.  Central Nervous System Involvement of Multiple Myeloma Presenting as Short-lasting Unilateral Neuralgiform Headache with Conjunctival Injection and Tearing: A Case Report.

Authors:  Victor S Wang; Ayesha Ahmad; Santiago Mazuera; Clinton G Lauritsen
Journal:  Neurohospitalist       Date:  2022-04-22

2.  Clinical Outcomes of BCMA CAR-T Cells in a Multiple Myeloma Patient With Central Nervous System Invasion.

Authors:  Ting Wang; Ting He; Lie Ma; Yazi Yang; Ru Feng; Yanping Ding; Yueming Shan; Bing Bu; Feifei Qi; Fei Wu; Xin-An Lu; Hui Liu
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.